Quick Takeaways
- Thomas Hess has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- No recent insider transactions are currently listed.
- Info
- Insider Ownership
Insider Trading & Ownership of Thomas Hess
- Location
- New York, NY
- Signature
- /s/ Randy Milby as Attorney-In-Fact for Thomas Hess
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Thomas Hess and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Hillstream BioPharma Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Thomas Hess
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNTN | Hillstream BioPharma Inc. | Chief Financial Officer | 11 Jan 2022 | |||
| VIVS | ORGANOVO HOLDINGS, INC. | President, CFO and PFO | 06 Oct 2021 |